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Serotonin receptors of the 5-HT2A subtype are robustly expressed in the cerebral cortex where 
they have been implicated in the pathophysiology and therapeutics of mental disorders and 
the actions of hallucinogens. Much less is known, however, about the specific cell types 
expressing 5-HT2A receptors in cortex. In the current study we use immunohistochemical and 
electrophysiological approaches in genetically modified mice to address the expression of the 
Htr2a gene and 5-HT2A receptors in cortex. We first use an EGFP-expressing BAC transgenic 
mice and identify three main Htr2A gene expressing neuronal populations in cortex.  The largest 
of these cell populations corresponds to layer V pyramidal cells of the anterior cortex, followed by 
GABAergic interneurons of the middle layers, and non-pyramidal cells of the subplate/Layer VIb. 
We then use 5-HT2A receptor knockout mice to identify an antibody capable of localizing 5-HT2A 
receptors in brain and use it to map these receptors. We find strong laminar expression of 5-HT2A 
receptors in cortex, especially along a diffuse band overlaying layer Va.  This band exhibits a strong 
anteroposterior gradient that closely matches the localization of Htr2A expressing pyramidal cells 
of layer V. Finally we use electrophysiological and immunohistochemical approaches to show that 
most, but not all, GABAergic interneurons of the middle layers are parvalbumin expressing Fast-
spiking interneurons and that these cells are depolarized and excited by serotonin, most likely 
through the activation of 5-HT2A receptors. These results clarify and extend our understanding 
of the cellular distribution of 5-HT2A receptors in the cerebral cortex.
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Subsequent attempts to expand on this early work and   localize 
5-HT2A receptors at the cellular and subcellular levels have relied 
mostly on the use of anti-5-HT2A receptor antibodies. Unfortunately, 
although several different antibodies directed against the N and the 
C terminus of the receptor have been used (Morilak et al., 1993; 
Willins et al., 1997; Hamada et al., 1998; Jakab and Goldman-Rakic, 
1998; Wu et al., 1998; Jansson et al., 2001; Martin-Ruiz et al., 2001; 
Miner et al., 2003; Doly et al., 2004; McDonald and Mascagni, 
2007), this work has yielded conflicting results in terms of the areal, 
cellular and subcellular distribution of 5-HT2A receptors (Morilak 
et al., 1993; Backstrom and Sanders-Bush, 1997; Willins et al., 1997; 
Hamada et al., 1998; Cornea-Hebert et al., 1999; Miner et al., 2003). 
In broad terms, there has been only limited congruency between 
the distributions of 5-HT2A receptor immunoreactivity reported 
by these different antibodies. Furthermore, the distribution of 
5-HT2A receptor immunoreactivity reported in most of these stud-
ies has also differed, in some cases quite substantially, from the 
distribution of 5-HT2A binding sites and 5-HT2A receptor mRNA 
identified using receptor autoradiographic and in situ hybridiza-
tion approaches. This has resulted in uncertainty regarding the 
distribution of 5-HT2A receptors in the brain.
In the present work we have taken advantage of genetically 
modified mice to re-examine the expression of Htr2A, the gene 
coding for the 5-HT2A receptor, and the 5-HT2A receptor protein 
itself in the cerebral cortex. We use three genetically modified mice 
strains in this study. First, we use BAC transgenic mice engineered 
to express EGFP under the control of the 5-HT2A receptor promoter 
IntroductIon
5-HT2A receptors are class A heptahelical receptors activated by sero-
tonin (5-Hydroxytryptamine, 5-HT) that signal, at least in part, by 
activating heterotrimeric G proteins of the Gαq-11 subtype (Hoyer 
et al., 1994). In the brain, 5-HT2A receptors are abundantly expressed 
in the anterior forebrain and especially in the anterior cerebral cor-
tex (Pazos et al., 1985; Hoyer et al., 1986) where they are thought 
to mediate at least some of the effects of serotonin (Hoyer et al., 
1994; Barnes and Sharp, 1999; Zhang, 2003; Béïque et al., 2007). 
Converging lines of evidence indicate that 5-HT2A receptors, espe-
cially those located in the prefrontal cortex, play an important role 
in the pathophysiology and therapeutics of neuropsychiatric dis-
orders including schizophrenia and depression and the mechanism 
of action of hallucinogens (Vollenweider et al., 1998; Dean, 2003; 
Weisstaub et al., 2006; Gray and Roth, 2007; Serretti et al., 2007).
The distribution of 5-HT2A receptors in the brain was originally 
outlined by studies using receptor autoradiographic approaches 
(Pazos et al., 1985; Blue et al., 1988; Lopez-Gimenez et al., 1997, 
2001) and was subsequently confirmed by studies using in situ 
hybridization (Mengod et al., 1990; Pompeiano et al., 1994; Wright 
et al., 1995). These complementary approaches outlined the distri-
bution of 5-HT2A binding sites and 5-HT2A receptor mRNA in the 
rodent brain and demonstrated that 5-HT2A receptors are expressed 
in the rodent cerebral cortex along a strong anteroposterior gradi-
ent that exhibits robust laminar specificity. The limited resolution 
of these techniques, however, precluded a cellular level analysis of 
5-HT2A receptor distribution.
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of  North  Carolina),  (5)  Rabbit  anti-5-HT2A  receptor  (1:300, 
Ab16028, Abcam), (6) rabbit anti-parvalbumin (1:2000, Swant), 
(7) Rabbit anti-calretinin (1:2000, Swant), (8) mouse anti-GABA 
(1:1000, Swant). The affinity purified rabbit anti-5-HT2A recep-
tor antibody was originally developed by Dr. Mark S. Brownfield, 
University of Wisconsin, Madison (Brownfield et al., 1998) and 
is currently distributed by ImmunoStar. This same antibody also 
appears to be distributed by other companies (Dr. M.S. Brownfield, 
personal communication) and may be the same antibody used 
by McDonald and Mascagni (2007) and by Doly et al. (2004). 
Secondary antibodies conjugated to Alexafluor 488 or Alexafluor 
568 were obtained from Molecular Probes/Invitrogen. Secondary 
antibodies conjugated to Dylight 488 or Cy3 were obtained from 
Jackson Immunoresearch. Biotinylated secondary antibodies were 
obtained from Vector labs. Immunoperoxidase staining was per-
formed using the Vectastain ABC kit (Vector Labs) using DAB as 
a substrate and nickel intensification. Sections stained for immun-
ofluorescence were mounted using Vectashield (Vector labs) while 
sections reacted using the HRP/DAB procedure were mounted, 
dehydrated in alcohol/xylene and coverslipped using Krystalon. 
Brain sections were imaged using an Olympus Fluoview laser scan-
ning confocal microscope equipped with Argon and Xenon lasers, 
or a Zeiss Axioskop microscope equipped with a Spot digital camera 
(Diagnostic Instruments). For experiments aimed at comparing the 
immunostaining in wild type and 5-HT2A receptor knockout mice, 
the slices were notched with a scalpel for identification purposes, 
mixed, and processed as a single batch to avoid any potential dif-
ferences in the immunolabeling procedure.
ElEctrophysIology
Whole cell electrophysiological recordings were obtained from 
neurons in cortical brain slices as previously described (Béïque 
et al., 2007; Yan et al., 2009). Briefly, mice aged between postnatal 
day 14 and 24 were anaesthetized with isofluorane and sacrificed 
by decapitation. The brain was cooled in ice cold Ringer (composi-
tion in mM: 119 NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2, 1 NaH2PO4, 
26.2 NaHCO3 and 22 glucose, bubbled to saturation with 95% 
O2–5% CO2) and cortical brain slices were cut at a nominal thick-
ness of 300 μM using a vibratome. Slices were allowed to recover in 
bubbled Ringer supplemented with 10 mM HEPES and then were 
transferred, one at a time, to a recording chamber on the stage of 
an upright microscope (Nikon E600). In this chamber, slices were 
continuously perfused with Ringer at 30° ± 1° C. In general EGFP 
expression in cortical interneurons was reasonably robust through 
the third and fourth postnatal week thus allowing for the targeting 
of EGFP expressing interneurons of the prefrontal, primary motor 
and primary sensory cortices using fluorescence and DIC imaging. 
In most experiments, whole-cell recordings were obtained using a 
potassium based intracellular recording solution (composition in 
mM: 125 KMeSO4, 5 KCl, 5 NaCl, 0.02 EGTA, 10 Hepes, 1 MgCl2, 
10 NaH2PO4, 4, ATP Mg salt, 0.3 GTP Na salt, pH 7.3). Recordings 
examining sIPSCs were conducted in the presence of 10 μM CNQX 
and used a cesium based intracellular solution containing high 
chloride to allow for the detection of isolated IPSCs as large inward 
currents (composition in mM: 130 CsCl, 10 EGTA, 15 Hepes, 10 
Phosphocreatine, 4 ATP Mg salt, 0.5 GTP Na salt, pH 7.3). We con-
firmed the effectiveness of this pharmacological   isolation of sIPSCs 
[5-HT2AR-EGFP  mice,  strain  Tg(Htr2a-EGFP)118Gsat/Mmcd, 
GENSAT]. Previous studies have shown that reporter gene expres-
sion cassettes within BACs experience limited positional effects 
from their insertion into the genome and thus expression of the 
reporter can be used to map the native expression of the gene of 
interest (Heintz, 2001; Gong et al., 2003). Therefore EGFP expres-
sion in these mice should identify Htr2A gene expressing neurons 
both in vivo and in vitro. Second, we used mice in which the 5-HT2A 
receptor has been genetically deleted (5-HT2A receptor knockout 
mice, Villalobos et al., 2005; Béïque et al., 2007). This knockout 
mouse makes it possible to unambiguously determine antibody 
specificity and labeling conditions for the immunolocalization of 
5-HT2A receptors in native tissues, and also greatly facilitates the 
identification of 5-HT2A receptor-mediated responses in vivo. Third 
and finally, we used B6/Cg-Tg(Thy1-YFPH)2Jrs/J mice (Thy1-YFP 
mice), which express YFP under the control of the Thy-1 promoter 
in pyramidal cell of layer Vb (Feng et al., 2000; Shepherd, 2009). 
This mouse provide an unambiguous laminar marker for the study 
of 5-HT2A receptor distribution in cortex. Together, these mice have 




All experiments described in the current report were carried out 
in  accordance  with  the  U.S.  Public  Health  Service’s  Policy  on 
Humane Care and Use of Laboratory Animals and were approved 
by the Institutional Animal Care and Use Committee at Wayne 
State University. Breeding colonies for each of the mice strains 
were maintained within the animal facilities of the Wayne State 
University  School  of  Medicine.  The  Tg(Htr2a-EGFP)118Gsat/
Mmcd mouse strain was originally obtained from the NIH’s Mutant 
Mouse Regional Resource Center at the University of California, 
Davis. The 5-HT2A receptor knockout mouse strain was originally 
obtained from Dr. Jay A. Gingrich (Villalobos et al., 2005) and 
has been crossed through several generations into C57Black and 
Swiss  Webster  backgrounds.  The  B6/Cg-Tg(Thy1-YFPH)2Jrs/J 
mouse strain was obtained from the Jackson labs. The 5-HT2A 
receptor knockout and Tg(Htr2a-EGFP)118Gsat/Mmcd strains 
were  maintained  as  heterozygote  ×  heterozygote  mating  pairs 
and the offspring were genotyped to select mice of the needed 
genotype. The B6/Cg-Tg(Thy1-YFPH)2Jrs/J strain was maintained 
as homozygote × wild type mating pairs and thus all offspring 
expressed YFP.
IMMunohIstochEMIstry and IMagIng
Adult mice were anaesthetized with a lethal dose of pentobarbital 
and perfused transcardially with PBS followed by ice cold 4% para-
formaldehyde. Brains were postfixed for 24–72 h in 4% parafor-
maldehyde at 4°C, washed in PBS and sectioned using a vibratome 
to produce horizontal or coronal sections nominally 50 μm thick. 
Standard immunohistochemical procedures were used to localize 
antigens of interest. The primary antibodies used in the current 
study were (1) rabbit anti-GFP (1:1000, Invitrogen), (2) chicken 
anti-GFP (1:1000, Aves Labs), (3) affinity purified rabbit anti-5-
HT2A receptor (1:100–1:1000, ImmunoStar), (4) Rabbit anti-5-HT2A 
receptor (1:1000, Ab51, a kind gift of Dr. Bryan L. Roth, University www.frontiersin.org  August 2010  | Volume 4  | Article 36  |  3
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The expression of EGFP in cortex exhibits a very strong laminar 
pattern which reflects the labeling of three main populations of 
cells. First, EGFP expression defines a strong band of pyramidal 
neurons in layer V. This band extends, in anterior coronal sections, 
from the medial prefrontal cortex to the insular cortex overlaying 
the rhinal fissure (Figure 1A) and exhibits a very strong anteropos-
terior gradient. As illustrated in Figure 1, the number of labeled 
pyramidal cells in this band is highest in the orbital cortex and 
decreases at posterior levels such that only scattered pyramidal 
cells are labeled at the level of the secondary somatosensory cor-
tex (Figures 1B,C). Second, EGFP expression defines a band of 
scattered non-pyramidal cells in Layer V and VIa (Figure 1C). In 
contrast to the band of pyramidal cells of layer V, this second band 
of cells does not exhibit an obvious anteroposterior gradation but 
rather appears relatively homogeneous through the visual cortex 
and laterally through the entorhinal cortex (Figures 1A3,C). Third, 
EGFP expression defines a narrow band of non-pyramidal cells 
immediately above the white matter (Figures 1 and 2), in what has 
been called the subplate, layer VIb or layer VII (Reep, 2000). These 
cells appear continuous with a group of EGFP expressing cells in 
the claustrum/endopiriform nucleus and form a thin sheet of EGFP 
expressing cells overlaying the entire corpus callosum. In addition 
to these three main cell populations, EGFP expression can also 
be detected in scattered pyramidal cells of layer III in the medial 
prefrontal, orbital and insular cortices (Figures 2B,C) as well as in 
sporadic non-pyramidal cells in layer I–III scattered through all 
cortical areas (e.g. Figures 1C and 2B).
Previous studies have reported developmental changes in the 
ability of 5-HT2A receptors to regulate neuronal excitability in the 
cerebral (prefrontal) cortex (Zhang, 2003; Béïque et al., 2004). 
In particular, these studies have shown that 5-HT2A receptors 
robustly depolarize pyramidal cells of layer V during the early 
postnatal period and that this effect progressively diminishes with 
age in spite of relatively constant levels of 5-HT2A receptor mRNA. 
Therefore we also examined the distribution of EGFP at postnatal 
day 8, when 5-HT2A robustly depolarize pyramidal cells of layer 
V, and at postnatal day 16 when the 5-HT2A receptor-mediated 
depolarizing responses approach those seen in adults (Béïque 
et al., 2004). As illustrated in Figure 3, EGFP expression in the 
anterior cerebral cortex at postnatal day 8 and 16 was qualitatively 
similar to that seen in adult mice. The main difference observed 
was stronger native EGFP fluorescence during the early postnatal 
period (not shown).
Validation of an anti-5-Ht2a receptor antibody
While GFP expression identifies cells capable of expressing the 
Htr2A  gene,  it  provides  only  indirect  information  regarding 
expression of the 5-HT2A receptor itself. Therefore we next sought 
to directly localize these receptors. We first used a commercially 
available  affinity  purified  antibody  directed  against  residues 
22–41 on the extracellular N terminus of the 5-HT2A receptor 
(ImmunoStar cat# 24288). As illustrated in Figure 4A, using this 
antibody we observed a strong, diffuse laminar staining of the 
cerebral cortex that was accompanied by variable labeling of the 
pyramidal cells apical dendritic trunk and secondary branches 
(Figure 4C). The diffuse laminar staining pattern observed with 
this antibody closely matched the laminar distribution of 5-HT2A 
using bicuculline (30 μM, n = 6 cells tested), which completely 
blocked all synaptic activity in the slice. Patch pipettes filled with 
these intracellular solutions exhibited resistances ranging from 2.5 
to 3.5 MΩ and series resistances ranging from 8 to 15 MΩ upon 
gaining whole cell access. Drugs were administered in the bath dis-
solved at known concentrations. Most drugs were obtained from 
Sigma. MDL100,907 was a kind gift of Dr. Kenner Rice (Laboratory 
of Medicinal Chemistry, NIDDK).
results
Htr2A gene expression in tHe cerebral cortex
To address the cellular distribution of 5-HT2A receptors in the cer-
ebral cortex we first examined Htr2A gene expression, as reported 
by EGFP, in 5-HT2AR-EGFP transgenic mice. The distribution of 
EGFP immunoreactivity in the forebrain of this mouse is illustrated 
in Figure 1. In broad terms, numerous EGFP expressing cells were 
observed in iso- and proisocortex, with much lower levels of expres-
sion in allocortex, including the pyriform, olfactory cortices and 
hippocampus. As previously noted in the preliminary GENSAT 
characterization of this mouse, this areal expression pattern is in 
general agreement with the results of in situ hybridization studies 
localizing the distribution of 5-HT2A receptor mRNA (Pompeiano 
et al., 1994; Wright et al., 1995). The main discrepancies in the 
anterior forebrain are the very low levels of EGFP expression in 
pyriform cortex, olfactory tubercle and striatum, where previous 
in situ hybridization studies have reported reasonably robust levels 
of 5-HT2A receptor mRNA expression.
Figure 1 | egFP expression in the forebrain of the 5-HT2Ar-egFP mouse. 
(A,B) Low magnification images illustrating the distribution of EGFP 
expressing cells in coronal and horizontal sections. Calibration bar = 2 mm. 
AC, anterior cingulate cortex; Aud, auditory cortex; Ent, Entorhinal cortex; 
Hipp, hippocampus; Ins, insular cortex; M1, primary motor cortex; Orb, orbital 
cortex; PL, prelimbic cortex; Rh, rhinal cortex; S1, primary somatosensory 
cortex; S2, secondary somatosensory cortex, Str, striatum. Low magnification 
images of parasagital brain sections for this mouse are available at the 
GENSAT web site. (C) Higher magnification images depicting the EGFP 
immunoreactivity in the insular [a in (B)] and secondary somatosensory cortex 
[b in (B)]. Calibration bar = 250 μm. In this figure EGFP was immunolocalized 
using a rabbit anti-GFP antibody and detected using immunoperoxidase 
histochemistry.Frontiers in Neuroscience  |  NeuroPharmacology    August 2010  | Volume 4  | Article 36  |  4
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could reduce this non-specific dendritic staining, but could not 
completely eliminate it. This limitation notwithstanding, these 
results indicate that the ImmunoStar antibody is suitable for the 
detection of 5-HT2A receptors in fixed brain sections.
In addition to the ImmunoStar anti-5-HT2A antibody reported 
above, we tested two additional anti-5-HT2A receptor antibodies. 
First we tested a commercially available rabbit polyclonal anti-
body against an unspecified epitope within the first 100 residues 
of the rat 5-HT2A receptor (AbCam; Cat # ab16028). We could 
not obtain staining above background in any region of cortex 
with this antibody. Second, we tested a different rabbit polyclonal 
antibody again directed against residues 22–41 of the 5-HT2A 
receptor (antibody Ab51, Willins et al., 1997). Consistent with 
previous observations (Willins et al., 1997; Martin-Ruiz et al., 
2001; Nocjar et al., 2002), this antibody stained both pyramidal 
and non-pyramidal cells in cortex with a strong punctuate pat-
tern (Figure 4D). However this staining showed little regional or 
laminar specificity, with the soma and proximal apical dendrite 
of pyramidal cells of layers II–VI exhibiting comparable labeling. 
Most importantly, Ab51 produced comparable staining in wild 
type and 5-HT2A receptor knockout mice indicating that, at least 
under our experimental conditions, this antibody does not pri-
marily recognize 5-HT2A receptors. We did not pursue any further 
studies with either of these antibodies. Unfortunately the widely 
used G186-1117 anti-5-HT2A receptor monoclonal antibody (Wu 
et al., 1998) originally distributed by Pharmingen is no longer 
available and could not be tested.
binding  sites  suggesting  specific  labeling  of  5-HT2A  receptors 
(Pazos et al., 1985; Blue et al., 1988; Mengod et al., 1990; Lopez-
Gimenez et al., 1997). However, because anti-5-HT2A receptor 
antibodies have been plagued by specificity issues, we sought to 
validate the immunostaining. As a first control, we   immunostained 
hippocampus, an area that is rich in pyramidal cells but where 
5-HT2A receptor expression is very low (Pazos et al., 1985; Mengod 
et al., 1990; Pompeiano et al., 1994; Wright et al., 1995) and is 
restricted to a small subset of non-pyramidal cells (Wright et al., 
1995; Shen and Andrade, 1998). As illustrated in Figure 4B, we 
observed only faint labeling in this region. To further test the spe-
cificity of this antibody we turned to 5-HT2A receptor knockout 
mice. As illustrated in Figure 4C, the laminar staining observed in 
cortex was completely absent in 5-HT2A receptor knockout mice. 
In contrast, the fainter pyramidal cell apical dendritic staining was 
still detectable in these mice. Dilution of the primary antibody as 
well as immunoabsorption through re-use of the antibody   solution 
Figure 2 | Cellular expression of egFP in the somatosensory, prefrontal 
and orbital cortices of 5-HT2Ar-egFP mice. (A) Confocal image illustrating 
the distribution of EGFP immunoreactive cells in the primary sensory and 
adjacent insular cortex. Calibration bar = 500 μm. (B) Distribution of EGFP in 
the medial prefrontal and medial orbital cortices. (C) Distribution of EGFP in 
the lateral orbital cortex. Ins, insular cortex; Orb, orbital cortex; PL, prelimbic 
cortex; S1, primary somatosensory cortex. EGFP was immunolocalized in 
horizontal sections using a rabbit anti-GFP antibody and detected using an 
Alexa 488 conjugated secondary goat anti-rabbit antibody. Images depict 
flattened confocal stacks containing 15–20 optical sections spanning 
20–30 μm along the z axis.
Figure 3 | expression of egFP in the anterior cerebral cortex during the 
early postnatal period. For these experiments EGFP was immunolocalized in 
horizontal sections using a rabbit anti-GFP antibody and detected using an 
Alexa 488 conjugated secondary goat anti-rabbit antibody. Mosaic composite 
images for each section were assembled from 9–12 subfields acquired with a 
digital camera.www.frontiersin.org  August 2010  | Volume 4  | Article 36  |  5
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iso- and   proisocortex exhibits a strong laminar staining pattern 
(Figure 5) with the most conspicuous staining located to the 
middle layers of cortex. This laminar pattern is most evident in 
sensory and motor cortices where a dense superficial and a second 
deeper and less dense band are clearly recognizable (Figures 4A 
and 5). In addition, in strongly stained material, it is possible to 
also recognize an additional weak band of immunoreactivity over 
layer I and a second weak band over layer VIb (Figures 4A,B). 
Previous receptor autoradiographic studies have assigned the 
densest 5-HT2A receptor band to either layer IV or to layer V. 
To identify the specific cortical layer(s) stained by the anti-5
-HT2A receptor antibody in midcortex we counterstained the 
brain sections using a fluorescent Nissl stain. This stain defines 
the densely packed layer IV in granular cortex and thus provides 
an unambiguous laminar landmark. As illustrated in Figure 6A, 
in primary somatosensory cortex the denser, more superficial 
5-HT2A receptor immunoreactive band localized to layer Va, 
immediately below layer IV, while the second, less dense band 
localized to deep layer V and upper layer VI. This laminar dis-
tribution in somatosensory cortex matches the careful mapping 
of 5-HT2A binding sites in this same area by Blue and colleagues 
in rats (Blue et al., 1988).
To extend this laminar analysis to agranular areas, which consti-
tute the largest portion of the anterior cerebral cortex in rodents, 
we next took advantage of a transgenic mouse [B6/Cg-Tg(Thy1-
YFPH)2Jrs/J] in which the large pyramidal cells of layer Vb are 
unambiguously labelled by the expression of YFP (Bartos et al., 
2007; Shepherd, 2009). As illustrated for primary motor cortex in 
IMMunohIstochEMIcal localIzatIon of 5-ht2a rEcEptors In thE 
cErEbral cortEx
Figure 5 illustrates the distribution of 5-HT2A receptor immu-
noreactivity in the cerebral cortex. In general, there is a very 
strong  areal  correspondence  between  anti-5-HT2A  receptor 
immunoreactivity and Htr2A expression as reported by EGFP 
expression in the 5-HT2AR-EGFP mouse. This is most dramati-
cally illustrated by the very close correspondence between the 
distribution of EGFP expressing pyramidal cells of layer V and 
the 5-HT2A receptor immunoreactive band in this same layer 
(Figures 1B and 4B). These results support the idea that EGFP 
expression in the 5-HT2AR-EGFP mouse labels 5-HT2A receptor 
expressing cells in the anterior forebrain. The main discrepan-
cies observed in the anterior forebrain concerned the pyriform 
cortex, olfactory tubercle, and to a lesser extent the striatum. In 
these three areas we observed only very few and widely scattered 
EGFP expressing cells but robust 5-HT2A receptor immunoreac-
tivity. In situ hybridization (Pazos et al., 1985; Blue et al., 1988; 
Lopez-Gimenez et al., 1997, 2001) and receptor autoradiographic 
studies (Mengod et al., 1990; Pompeiano et al., 1994; Wright et al., 
1995) have consistently detected expression of 5-HT2A receptors 
in these areas. Furthermore the anti 5-HT2A receptor antibody 
staining in these areas was likely specific, since only background 
staining was detected in these areas in the 5-HT2A receptor knock-
out mouse (not shown). Therefore it seems likely that these dis-
crepancies reflect silencing of the EGFP expression cassette in 
these areas in the 5-HT2AR-EGFP mouse rather than non-specific 
antibody staining. The 5-HT2A receptor   immunoreactivity in 
Figure 4 | 5-HT2A receptor detection in the cerebral cortex using an 
anti-5HT2A receptor antibody. (A,B) 5-HT2A receptor immunoreactivity in the 
anterior cerebral cortex (A) and hippocampus (B) in a wild type mouse. 5-HT2A 
receptor immunodetection for these images used the ImmunoStar antibody 
at a 1:100 dilution and HRP/DAB detection (A2,B2). (A1) and (B1) depict 
pseudocoloring of images in (A2) and (B2). Calibration bar: 1 mm. (C) 5-HT2A 
receptor immunoreactivity in the cerebral cortex of wild type and 5-HT2A 
receptor knockout (KO) mice. Notice the disappearance of the layer V band in 
the KO mouse. 5-HT2A receptor immunodetection for these images used the 
ImmunoStar antibody at a 1:500 dilution and an Alexa 488 conjugated 
secondary antibody. Images are pseudocolored for emphasis and depict 
comparable flattened confocal stacks through motor-frontal cortex. (D) 
Immunoreactive staining obtained with the Ab51 antibody. Images 
correspond to single confocal sections through layers V and VI of the M1 
region in a wild type and a 5-HT2A receptor knockout mice. (C,D) Calibration 
bar: 200 μm.Frontiers in Neuroscience  |  NeuroPharmacology    August 2010  | Volume 4  | Article 36  |  6
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The  diffuse  5-HT2A  receptor  immunoreactivity,  while 
  unambiguous, offered few clues as to the cellular localization of 
5-HT2A receptors. Unfortunately, in the current material, we could 
not unambiguously resolve the 5-HT2A receptor immunoreactive 
cellular elements responsible for the banded pattern. To try to gain 
Figure 6B, the more superficial 5-HT2A receptor immunoreactive 
band was clearly localized immediately above the YFP immuno-
reactive somata, that is to say in layer Va, while the deeper band 
overlapped the YFP labelled cell layer (layer Vb). Similar results 
were observed in other agranular areas.
Figure 6 | Laminar distribution of 5-HT2A receptor immunoreactivity in 
motor-frontal cortex. (A) Laminar distribution of 5-HT2A receptors (red) in mouse 
cortex counterstained using a fluorescent Nissl dye (blue, Neurotrace, Invitrogen). 
(B) 5-HT2A receptors (red) distribution in the motor (agranular) cortex of the 
Thy1-YFP mouse. In this mouse YFP (green) is expressed in the large pyramidal 
cells of layer Vb. Notice the double banded distribution of YFP expressing cells that 
characterizes agranular cortex in this mouse (Shepherd, 2009). (C) 5-HT2A receptor 
distribution in the cortex of the 5-HT2AR-EGFP mouse. Calibration bar: 100 μm.
Figure 5 | 5-HT2A receptor distribution in mouse cerebral cortex. (A1-A2) 
Distribution of 5-HT2A receptor immunoreactivity in coronal sections through 
the mouse brain. (B1-B2) Distribution of 5-HT2A receptor immunoreactivity in a 
horizontal section through the mouse brain. The images in (A1-A2) and (B1-B2) 
were obtained using the ImmunoStar antibody. (A2) and (B2) depict 
pseudocolor renditions of the images illustrated in (A1) and (B1) respectively. 
Calibration bar: 1 mm. Aud, auditory cortex; Ent, Entorhinal cortex; Hipp, 
hippocampus; Ins, insular cortex; M1, primary motor cortex; Orb, orbital 
cortex; PL, prelimbic cortex; Rh, rhinal cortex; S1, primary somatosensory 
cortex; Str, striatum.www.frontiersin.org  August 2010  | Volume 4  | Article 36  |  7
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The vast majority of non-pyramidal cells in layers V and VIa 
can be expected to be GABAergic interneurons. In agreement 
with this idea, many EGFP expressing non-pyramidal cells of 
midcortex in the 5-HT2AR-EGFP mouse are immunoreactive 
for GABA (Figure 7C). Cortical GABAergic interneurons are 
highly heterogeneous and differ in terms of their morphology 
and projections, intrinsic electrophysiological properties, and 
the expression of specific marker genes (Kawaguchi and Kubota, 
1997; Markram et al., 2004; Miyoshi et al., 2007; Ascoli et al., 
2008). It is generally well accepted that GABAergic interneurons 
can be divided into two main types, fast-spiking (FS) and non 
fast-spiking (nFS) interneurons (Kawaguchi and Kubota, 1997; 
Markram et al., 2004; Miyoshi et al., 2007). This distinction, 
while based upon electrophysiological properties, is thought 
to reflect a fundamental division in interneuronal subtypes. 
Therefore we recorded from GFP expressing non-pyramidal cells 
and examined their spiking characteristics in response to con-
stant current depolarizing stimuli (Kawaguchi and Kubota, 1997; 
Markram et al., 2004; Miyoshi et al., 2007). Most EGFP express-
ing interneurons could be classified as FS interneurons of the 
continuous firing or stuttering types (16 out of 25 cells recorded, 
Figure 7A). The remaining cells represented nFS interneurons 
(9 out of 25 cells recorded, Figure 7B). A fraction of these cells 
insight into this issue we colocalized EGFP and 5-HT2A receptors 
in the 5-HT2A R-EGFP mouse. As illustrated in Figure 6C, EGFP 
immunoreactive somata were located mostly between, but also over-
laping, the two 5-HT2A receptor immunoreactive bands (Figure 6C). 
However, again, the weak dendritic EGFP and diffuse 5-HT2A recep-
tor staining did not allow us to unambiguously assess colocalization. 
In the Thy1-YFP mouse, where pyramidal cell dendritic arboriza-
tions can be resolved in superb detail, the 5-HT2A receptor immuno-
reactive band located in layer Va was observed to overlap with a dense 
YFP immunoreactive neuropil composed predominantly of fine, 
horizontal and oblique oriented spiny dendrites (not shown).
Htr2A gEnE and 5-ht2a rEcEptor ExprEssIon In gabaergic 
IntErnEurons
As outlined above, many EGFP expressing cells in the 5-HT2AR-
EGFP  mouse  lack  a  clear  apical  dendrite  and  thus  represent 
non-pyramidal cells. Such cells are most commonly located in 
layers V and VI and are distributed along two bands, a broad 
band of scattered cells located in layers V and VIa, and a sec-
ond narrow band of cells located in the subplate/layer VIb. Here 
we investigated the cells located in the more superficial of these 
bands. The cells located in deeper cell band will be the subject 
of a separate report.
Figure 7 | Characterization of egFP expressing gABAergic interneurons. 
(A,B) EGFP expressing interneurons fall into two broad classes based upon their 
spiking characteristics, FS interneurons (A) and nFS interneurons (B), a subset 
of which exhibit delayed spiking (B2). (C) Immunocolocalization of EGFP (green) 
and GABA (red) in layer V of motor-frontal cortex. Calibration bar: 20 μm. (D) 
Immunocolocalization of EGFP (green) and parvalbumin (red) in the deep layers 
of motor-frontal cortex. Arrows point to a subset of double labeled cells. 
Calibration bar 200 μm. (e) Immunocolocalization of EGFP (green) and 
parvalbumin (red) in motor-frontal cortex. Calibration bar: 500 μm. (F) 
Immunocolocalization of EGFP (green) and calretinin (red) in the same area.Frontiers in Neuroscience  |  NeuroPharmacology    August 2010  | Volume 4  | Article 36  |  8
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observed little if any coexpression of EGFP and calretinin, a marker 
for a subset of nFS interneurons, in the cortex of the 5-HT2AR-EGFP 
mouse (Figure 7F).
While the effects signaled by 5-HT2A receptors in pyramidal cells 
have been extensively investigated (e.g. Araneda and Andrade, 1991; 
Aghajanian and Marek, 1997; Zhang, 2003; Béïque et al., 2007), little 
is currently known about the effects signaled by 5-HT2A receptors 
in GABAergic interneurons. Therefore we examined the effects of 
serotonin or of the preferential 5-HT2 receptor agonist α-methyl-
serotonin on EGFP expressing interneurons of layers V and VIa. As 
illustrated in Figure 8A, the most common effect observed in these 
experiments was a membrane depolarization (9 of 15 cells tested, 7 
FS and 2 nFS cells). Overall the depolarizations induced by serotonin 
(30 μM) averaged 7.6 ± 2 mV (mean ± SEM, n = 9 cells) and ranged 
from barely detectable (1–2 mV) to capable of initiating sustained 
spiking activity (Figure 8A). No obvious effect of serotonin on mem-
brane potential was seen in the remaining six cells.
The serotonin-induced depolarization observed in EGFP express-
ing GABAergic interneurons could be mediated by any number 
of serotonin receptors. The pharmacological   dissection of this 
displayed a characteristic delayed spiking (Figure 7B2, n = 5 
cells) and thus resembled the late spiking interneuron subtype 
previously described by Kawaguchi and Kubota (Kawaguchi and 
Kubota, 1997).
Fast-spiking interneurons are characterized neurochemically 
by the expression of the calcium binding protein parvalbumin 
(Markram et al., 2004; Ascoli et al., 2008) and many EGFP expressing 
non-pyramidal cells were found to express this protein (Figure 7D). 
Parvalbumin expressing interneurons are distributed throughout 
cortex but only a very modest fraction of the parvalbumin express-
ing cells in layers II–III were found to coexpress EGFP (4/274 or 
1.4% of all PV+ cells examined). This observation is consistent 
with the low number of EGFP positive cells in the superficial lay-
ers of cortex. In contrast, in layer V and especially in layer VIa, a 
much larger fraction of the parvalbumin-immunoractive cells was 
found to coexpress EGFP (74/483 or 15.3% of PV+ cells examined, 
Figure 7E). Interneurons of the nFS type represent a highly hetero-
geneous group (Kawaguchi and Kubota, 1997; Miyoshi et al., 2007) 
and we did not conduct a systematic effort to identify neurochemi-
cal markers for other Htr2A expressing interneurons. However, we 
Figure 8 | 5-HT depolarizes egFP expressing interneurons and increase 
siPSCs recorded in pyramidal cells through the activation of 5-HT2A 
receptors. (A) Administration of α-methyl-5-HT (30 μM) depolarizes and excites an 
EGFP expressing FS interneuron (left panel). (B) Administration of 5-HT (30 μM) in 
the presence of tropisetron (1 μM, to block 5-HT3 receptors) and CNQX (10 μM to 
block AMPA/kainite receptors) results in a large increase in sIPSCs. Subsequent 
administration of bicuculline (30 μM) blocks all spontaneous synaptic activity in the 
slice, thus confirming that the recorded synaptic currents represented sIPSCs. (C) 
Plots illustrating the effect of 5-HT (30 μM) on sIPSC frequency recorded from 
pyramidal cells of layer V in slices derived from wild type mice, in slices derived 
from wild type mice but pretreated (>10 min) with the 5-HT2A receptor antagonist 
MDL100,907 (1 μM) and in slices derived from 5-HT2A receptor knockout mice.www.frontiersin.org  August 2010  | Volume 4  | Article 36  |  9
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only in a subset of the cells natively expressing the Drd1a gene 
(http://www.gensat.org/cre.jsp). Furthermore, a recent study has 
also suggested that even within a single cell type, transgenes may 
not be universally expressed (Shuen et al., 2008). These anomalies 
presumably reflect some positional silencing and/or the loss of 
regulatory regions not included in the BAC. Therefore it is possible 
that EGFP may label only a subset of Htr2A expressing cells in the 
5-HT2AR-GFP mouse. In addition, Htr2A gene expression does not 
guarantee expression of 5HT2A receptor protein. These concerns 
notwithstanding, the close correspondence between EGFP and 
5-HT2A receptor mRNA expression observed at the macroscopic 
level suggests that most cell populations expressing the Htr2A gene 
are likely labeled in this mouse. However it remains possible that 
EGFP may label only a fraction of the cells natively expressing the 
Htr2A gene and 5-HT2A receptors, and thus that EGFP may func-
tion more like a trace label for specific cell populations rather than 
a universal tag for Htr2A gene expressing cells.
Given the well documented expression of 5-HT2A receptor in 
cortex, the most striking finding from the present study is the very 
selective expression of the Htr2A gene in specific neuronal popula-
tions of the cerebral cortex. Numerically the largest labeled popu-
lation corresponded to layer V pyramidal neurons of the anterior 
cerebral cortex. These cells show a remarkable graded anteroposte-
rior distribution that likely accounts for the strong anteroposterior 
gradient in 5-HT2A receptor expression in cortex (Pazos et al., 1985; 
Blue et al., 1988; Lopez-Gimenez et al., 1997, and current work). 
This strongly localized expression contrasts with the much more 
widespread expression of 5-HT2A receptors suggested by previous 
studies using anti-5-HT2A receptor antibodies (Morilak et al., 1993; 
Willins et al., 1997; Hamada et al., 1998; Jakab and Goldman-Rakic, 
1998; Wu et al., 1998; Cornea-Hebert et al., 1999). Discrepancies in 
the apparent distribution of 5-HT2A receptors when localized using 
anti-5-HT2A receptor antibodies and receptor autoradiography have 
been noted previously, and have been attributed to the ability of the 
antibodies to recognize immature forms of the receptor (Nocjar 
et al., 2002; McDonald and Mascagni, 2007) or to intracellular seg-
mentation (Jakab and Goldman-Rakic, 1998). These discrepancies, 
however, generally persist even when considering 5-HT2A receptor 
mRNA distribution, as for example in the observation of strong 
staining of pyramidal cells of the CA1 region of the hippocampus 
(e.g. Cornea-Hebert et al., 1999), a group of cells that expresses 
few if any 5-HT2A receptors (Pazos et al., 1985; Mengod et al., 1990; 
Ciaranello et al., 1993; Wright et al., 1995; Lopez-Gimenez et al., 
1997). Therefore we believe antibody cross-reactivity with non 
5-HT2A receptor epitopes offers a more likely explanation for this 
discrepancy. As such, these considerations suggest a need to revisit 
previous work relying on immunodetection of 5-HT2A receptors 
in central neurons.
Htr2A gene expression in the cortex of the 5-HT2AR-EGFP 
mouse is not restricted to pyramidal cell but also extends to non-
pyramidal cells, and specially GABAergic interneurons. A large frac-
tion of these cells are parvalbumin-expressing FS interneurons, an 
observation that is consistent with previous in situ hybridization 
studies reporting coexpression of 5-HT2A receptor and parvalbumin 
mRNA in cortex (de Almeida and Mengod, 2007; Puig et al., 2010). 
These Htr2A expressing GABAergic interneurons form an extensive 
band of cells scattered through the middle layers and extending 
effect however was made difficult by the presence of   considerable 
desensitization to repeated applications of serotonin (not shown). 
Interneurons, including FS interneurons provide a highly conver-
gent synaptic input onto pyramidal cells (Bartos et al., 2007) and 
therefore the sIPSC frequency detected within pyramidal cells can 
be used to assess the integrated activity of interneurons presynaptic 
to the recorded cell. This provided an alternative for examining the 
possible role of 5-HT2A receptors in the serotonin-induced depo-
larization. As predicted from the direct recordings from EGFP 
expressing  interneurons,  administration  of  serotonin  (30  μM) 
greatly increased the sIPSC frequency recorded from pyramidal 
cells of layer V, and this effect persisted even in slices pretreated 
with tropisetron (1 μM) to block 5-HT3 receptors (n = 5 cells, 
Figure 8B). These observations are consistent with similar obser-
vations in rat by Zhou and Hablitz (1999). The serotonin-induced 
increase in sIPSC frequency was completely blocked by pretreat-
ment with the selective 5-HT2A receptor antagonist MDL100,907 
(1 μM, Figure 8C) while 5-HT administration had no detectable 
effect on sIPSC frequency in slices derived from 5-HT2A receptor 
knockout mice (Figure 8C). These results indicate that a popula-
tion of GABAergic interneurons in the cerebral cortex is excited 
by 5-HT2A receptor activation.
dIscussIon
While the distribution of 5-HT2A receptors in the brain has been 
mapped at a macroscopic level using receptor autoradiographic 
and in situ hybridization approaches, the precise cellular elements 
expressing 5-HT2A receptors in cortex have remained much less well 
understood. In the current work we have readdressed the distribu-
tion of 5-HT2A receptors in the cerebral cortex by taking advantage 
of genetically modified mice. The results of these studies lead us to 
conclude that 5-HT2A receptors in cortex are expressed predomi-
nantly by three discrete populations of cells in the cerebral cortex: 
layer V pyramidal cells of the anterior cerebral cortex, a subpopula-
tion of GABAergic interneurons restricted to the middle layers of 
cortex, and non-pyramidal cells of the subplate/layer VIb.
Previous studies have suggested that, because of their large size, 
BACs experience limited positional effect from their insertion into 
the mouse genome, and therefore that expression of EGFP from 
the engineered BAC should recapitulate expression of the gene of 
interest (Heintz, 2001; Gong et al., 2003). In the current study we 
observed very good correspondence between the distribution of 
EGFP and 5-HT2A receptors in the cerebral cortex of the 5-HT2AR-
EGFP mouse. Furthermore, we also noted a very good correspond-
ence between the distribution of EGFP in mouse cortex and the 
distribution of 5-HT2A receptor mRNA and 5-HT2A binding sites 
previously reported in rat cortex. This strong correspondence sup-
ports the idea that EGFP expression in the 5-HT2AR-EGFP mouse 
identifies specific cell populations expressing 5-HT2A receptors 
in cortex.
While this approach identifies Htr2A gene expressing cell popu-
lations, it is important to note that the extent and completeness of 
the labeling of Htr2A expressing cells is less certain. For example in 
a series of six Drd1A (Dopamine receptor 1A) BAC mice generated 
by the GENSAT [g(Drd1a-cre)150 Gsat, Tg(Drd1a-cre)262 Gsat, 
Tg(Drd1a-cre)164 Gsat, Tg(Drd1a-cre)266 Gsat, Tg(Drd1a-cre)217 
Gsat and Tg(Drd1a-cre)242 Gsat], four expressed the   transgene Frontiers in Neuroscience  |  NeuroPharmacology    August 2010  | Volume 4  | Article 36  |  10
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postsynaptic structures, including dendritic spines. Such a synaptic 
localization would be consistent with the recent report that 5-HT2A 
receptor expression is reduced in PSD-95 knockout mice (Abbas 
et al., 2009) but needs to be confirmed using better characterized 
antibodies. In contrast, Doly et al. (2004) reported a non-synaptic 
dendritic localization for these receptors in preliminary studies 
using an antibody validated using 5-HT2A knockout mice. Clearly 
further studies are needed to resolve this important issue.
At a functional level, the present results suggest that, far from being 
widespread regulators of cortical pyramidal neurons, 5-HT2A recep-
tors are much more likely to play a circumscribed role mediating the 
effects of serotonin in the cerebral cortex. Specifically, the dense and 
selective localization of these receptors to layer Va strongly suggests a 
role regulating thalamic inputs to the anterior cerebral cortex. This 
idea is based upon recent work showing that thalamic input to rodent 
primary sensory (granular) cortex is divided into two anatomically 
segregated streams (Brecht, 2007), the lemniscal pathway that origi-
nates in the ventral posterior medial nucleus, terminates in layer IV 
and carries information regarding whisker deflections and the paral-
emniscal pathways that originates in the posterior medial nucleus, 
terminates in layer Va and carries information regarding “whisking”, 
the exploration-related movement of the whiskers. Thalamic inputs 
to agranular regions in the frontal cortex similarly receive overlapping 
input from multiple thalamic nuclei and may be similarly organized. 
Therefore, 5-HT2A receptors, by virtue of their robust and selective 
expression in layer Va, would appear to be ideally located to mediate 
the serotonergic modulation of thalamocortical information along 
the paralemniscal (or comparable) pathway. In addition, the expres-
sion of 5-HT2A receptors on FS GABAergic interneurons suggest a 
role in the regulation of gamma oscillations (Bartos et al., 2007), a 
possibility that has received independent support from the recent 
work by Puig et al. (2010) showing that raphe stimulation modulates 
gamma oscillation in cortex by activating 5-HT1A and also possibly 
5-HT2A receptors. Gamma oscillations are thought to provide tempo-
ral structure for cortical processing including the possible “binding” 
of sensory streams into coherent percepts (Bartos et al., 2007 and 
references therein). Combined, these considerations indicate that 
5-HT2A receptors are expressed at loci critical for controlling infor-
mation processing in cerebral cortex. It is tempting to speculate that 
the location of 5-HT2A receptors at such sites, if preserved in humans, 
could contribute to the hallucinogenic activity that is the hallmark 
of 5-HT2A receptor agonists.
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throughout iso- and proisocortex. Administration of serotonin 
depolarizes and excites these cells and also increases spontaneous 
GABAergic synaptic transmission onto pyramidal cells of layer V 
through the activation of 5-HT2A receptors. These results suggest 
that GABAergic interneurons, especially FS interneurons, of the 
cerebral cortex express functional 5-HT2A receptors and are regu-
lated by serotonin in the mouse cortex. Admittedly, these functional 
studies were, by necessity, conducted on young animals. However 
the relatively conserved Htr2A gene expression pattern observed 
during postnatal development in the 5-HT2AR-EGFP mouse sug-
gests these findings should be extensible to adult animals. Overall 
these observations are consistent with, and extend previous work in 
rat cortex (Zhou and Hablitz, 1999; Foehring et al., 2002) suggesting 
a role for serotonin receptors of the 5-HT2 family (subtypes 2A, 2B 
and 2C) in the control of GABAergic interneurons.
While the results above identify specific cell populations express-
ing 5-HT2A receptors in the cerebral cortex, they do not address the 
subcellular localization of these receptors. The strong correspond-
ence between 5-HT2A binding sites and 5-HT2A receptor mRNA has 
been interpreted to indicate that these receptors are localized to the 
somatodendritic region, although the precise localization in this 
compartment is less certain. Previous observations using mostly 
the G186-1117 antibody (Jakab and Goldman-Rakic, 1998; Wu 
et al., 1998; Cornea-Hebert et al., 1999), but also other antibodies 
(Willins et al., 1997; Hamada et al., 1998; McDonald and Mascagni, 
2007), have led to the widely accepted idea that 5-HT2A receptors 
are targeted to the apical dendritic trunk of pyramidal cells. In the 
current study we detected faint but clearly detectable staining of the 
pyramidal cell apical trunk and primary dendrites, in addition to 
the stronger, diffuse laminar staining. A similar staining pattern has 
also been observed in three additional studies (Hamada et al., 1998; 
Doly et al., 2004; McDonald and Mascagni, 2007). In our hands the 
apical dendritic trunk staining was still detectable in the 5-HT2A 
receptor knockout mice while the laminar staining was completely 
eliminated (but see Doly et al., 2004), suggesting it does not rep-
resent 5-HT2A receptor labeling. These results lead us to conclude 
that 5-HT2A receptors are neither targeted to the apical dendritic 
shaft nor uniformly distributed on the apical dendrite of pyramidal 
cells but rather cluster primarily within a narrow band overlapping 
layer Va. In the current experiments, we could not resolve the spe-
cific cellular elements labeled within this immunoreactive band. 
Our current hypothesis is that this diffuse labeling may reflect low 
density expression of 5-HT2A receptors in fine dendritic processes, 
but other possibilities cannot be ruled out. Ultrastructural stud-
ies examining the distribution of 5-HT2A receptors in the middle 
layers of cortex have reported the labeling of different subcellular 
compartments depending on the antibody used. Hamada et al. 
(1998) and Miner et al. (2003) have reported 5-HT2A expression in www.frontiersin.org  August 2010  | Volume 4  | Article 36  |  11
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